2000
DOI: 10.1016/s0960-0760(00)00126-6
|View full text |Cite
|
Sign up to set email alerts
|

Differential estrogen receptor binding of estrogenic substances: a species comparison

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

11
159
0
3

Year Published

2002
2002
2016
2016

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 271 publications
(173 citation statements)
references
References 45 publications
11
159
0
3
Order By: Relevance
“…These results are in conflict with our earlier studies in which estradiol benzoate was administered to rats during the neonatal period of life between days 5 th and 11 th , showing that the numbers of undifferentiated and differentiating type A spermatogonia were increased at day 15 th [44]. One of the possible explanations for these discrepancies can be the use of an estradiol compound (estradiol benzoate) in our previous study instead of pure E, which binding affinity to the human and murine ERα seems to be 6-10-fold reduced in comparison with E [45]. As the ERα is the main ER expressed in the rat pituitary gland [46] the differences in the effects exerted by both substances could be attributed to their different action on gonadotropins secretion, suggesting inhibition of FSH by E. The selective suppression of FSH action in immature rats by passive immunisation caused a significant reduction in Sertoli cells and spermatogonia numbers, but spermatocytes were more resistant to this conditions [47].…”
Section: Discussionmentioning
confidence: 78%
“…These results are in conflict with our earlier studies in which estradiol benzoate was administered to rats during the neonatal period of life between days 5 th and 11 th , showing that the numbers of undifferentiated and differentiating type A spermatogonia were increased at day 15 th [44]. One of the possible explanations for these discrepancies can be the use of an estradiol compound (estradiol benzoate) in our previous study instead of pure E, which binding affinity to the human and murine ERα seems to be 6-10-fold reduced in comparison with E [45]. As the ERα is the main ER expressed in the rat pituitary gland [46] the differences in the effects exerted by both substances could be attributed to their different action on gonadotropins secretion, suggesting inhibition of FSH by E. The selective suppression of FSH action in immature rats by passive immunisation caused a significant reduction in Sertoli cells and spermatogonia numbers, but spermatocytes were more resistant to this conditions [47].…”
Section: Discussionmentioning
confidence: 78%
“…The lack of effect of 17β-estradiol on arachidonic acid release observed in this report is in line with previous reported findings [69] and suggests that the estrogen receptors are not involved in PCB-induced arachidonic acid release. Also, the estrogen-like activities of CB47, CB52, CB118 and CB153 [70,71] does not correlate with their ability to induce eicosanoid synthesis and arachidonic acid release in platelets. Thus, the effects observed for anti-estrogens on CB52-induced eicosanoid formation suggest that PCBs might activate cPLA 2 -α by binding to a binding site distinct from the estrogen receptors.…”
Section: Discussionmentioning
confidence: 89%
“…It should be noted that the cell lines used in the present study contained human oestrogen receptors and a slight difference of the extracts to activate murine oestrogen receptors cannot be ruled out. However, studies by Matthews et al (2000) showed that human and mouse ER react in a very similar manner to steroidal and anti-oestrogenic compounds. We therefore expect that differences between activation of human versus murine oestrogen receptors by the steroid hormones tested will be quantitative rather than qualitative.…”
Section: Discussionmentioning
confidence: 99%